T. Blesken

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

C. Akdis, M. Akdiş, K. Blaser, 1996, The Journal of clinical investigation.

Role of interleukin 10 in specific immunotherapy.

C. Akdis, B. Wüthrich, M. Akdiş, 1998, The Journal of clinical investigation.

Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro

C. Akdis, M. Akdiş, C. Heusser, 1997, European journal of immunology.

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants

C. Akdis, M. Akdiş, K. Blaser, 1998, European journal of immunology.

Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.

C. Akdis, B. Wüthrich, C. Heusser, 1997, The Journal of allergy and clinical immunology.

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

C. Akdis, M. Akdiş, K. Blaser, 1998, The Journal of allergy and clinical immunology.

Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA‐DRB1*0405 by a FXXL motif

C. Akdis, Wymann, Akdis, 1999, Immunology.